178 related articles for article (PubMed ID: 37202167)
1. Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis.
Chiò A; Moglia C; Canosa A; Manera U; Grassano M; Vasta R; Palumbo F; Gallone S; Brunetti M; Barberis M; De Marchi F; Dalgard C; Chia R; Mora G; Iazzolino B; Peotta L; Traynor BJ; Corrado L; D'Alfonso S; Mazzini L; Calvo A
Neurology; 2023 Jul; 101(1):e83-e93. PubMed ID: 37202167
[TBL] [Abstract][Full Text] [Related]
2. ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion.
Chiò A; Mora G; Sabatelli M; Caponnetto C; Lunetta C; Traynor BJ; Johnson JO; Nalls MA; Calvo A; Moglia C; Borghero G; Trojsi F; La Bella V; Volanti P; Simone I; Salvi F; Logullo FO; Riva N; Carrera P; Giannini F; Mandrioli J; Tanel R; Capasso M; Tremolizzo L; Battistini S; Murru MR; Origone P; Zollino M; Penco S; ; ; Mazzini L; D'Alfonso S; Restagno G; Brunetti M; Barberis M; Conforti FL
Neurobiol Aging; 2016 Mar; 39():218.e5-8. PubMed ID: 26733254
[TBL] [Abstract][Full Text] [Related]
3. C9orf72 hexanucleotide repeat expansions and Ataxin 2 intermediate length repeat expansions in Indian patients with amyotrophic lateral sclerosis.
Narain P; Gomes J; Bhatia R; Singh I; Vivekanandan P
Neurobiol Aging; 2017 Aug; 56():211.e9-211.e14. PubMed ID: 28527524
[TBL] [Abstract][Full Text] [Related]
4. The repeat length of
Tang L; Chen L; Liu X; He J; Ma Y; Zhang N; Fan D
Front Neurol; 2022; 13():939775. PubMed ID: 35989899
[TBL] [Abstract][Full Text] [Related]
5. Exploring the phenotype of Italian patients with ALS with intermediate
Chio A; Moglia C; Canosa A; Manera U; Grassano M; Vasta R; Palumbo F; Gallone S; Brunetti M; Barberis M; De Marchi F; Dalgard C; Chia R; Mora G; Iazzolino B; Peotta L; Traynor B; Corrado L; D'Alfonso S; Mazzini L; Calvo A
J Neurol Neurosurg Psychiatry; 2022 Aug; 93(11):1216-20. PubMed ID: 36008116
[TBL] [Abstract][Full Text] [Related]
6. ATXN2 polyQ intermediate repeats are a modifier of ALS survival.
Chiò A; Calvo A; Moglia C; Canosa A; Brunetti M; Barberis M; Restagno G; Conte A; Bisogni G; Marangi G; Moncada A; Lattante S; Zollino M; Sabatelli M; Bagarotti A; Corrado L; Mora G; Bersano E; Mazzini L; D'Alfonso S;
Neurology; 2015 Jan; 84(3):251-8. PubMed ID: 25527265
[TBL] [Abstract][Full Text] [Related]
7. C9orf72 and ATXN2 repeat expansions coexist in a family with ataxia, dementia, and parkinsonism.
Zhang M; Xi Z; Misquitta K; Sato C; Moreno D; Liang Y; Slow E; Rogaeva E; Tartaglia MC
Mov Disord; 2017 Jan; 32(1):158-162. PubMed ID: 28124431
[TBL] [Abstract][Full Text] [Related]
8. Genetic variability in sporadic amyotrophic lateral sclerosis.
Van Daele SH; Moisse M; van Vugt JJFA; Zwamborn RAJ; van der Spek R; van Rheenen W; Van Eijk K; Kenna K; Corcia P; Vourc'h P; Couratier P; Hardiman O; McLaughin R; Gotkine M; Drory V; Ticozzi N; Silani V; Ratti A; de Carvalho M; Mora Pardina JS; Povedano M; Andersen PM; Weber M; Başak NA; Shaw C; Shaw PJ; Morrison KE; Landers JE; Glass JD; van Es MA; van den Berg LH; Al-Chalabi A; Veldink J; Van Damme P
Brain; 2023 Sep; 146(9):3760-3769. PubMed ID: 37043475
[TBL] [Abstract][Full Text] [Related]
9. OPTN p.Met468Arg and ATXN2 intermediate length polyQ extension in families with C9orf72 mediated amyotrophic lateral sclerosis and frontotemporal dementia.
Farhan SMK; Gendron TF; Petrucelli L; Hegele RA; Strong MJ
Am J Med Genet B Neuropsychiatr Genet; 2018 Jan; 177(1):75-85. PubMed ID: 29080331
[TBL] [Abstract][Full Text] [Related]
10. Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders.
Lattante S; Millecamps S; Stevanin G; Rivaud-Péchoux S; Moigneu C; Camuzat A; Da Barroca S; Mundwiller E; Couarch P; Salachas F; Hannequin D; Meininger V; Pasquier F; Seilhean D; Couratier P; Danel-Brunaud V; Bonnet AM; Tranchant C; LeGuern E; Brice A; Le Ber I; Kabashi E;
Neurology; 2014 Sep; 83(11):990-5. PubMed ID: 25098532
[TBL] [Abstract][Full Text] [Related]
11. Genetics screening in an Italian cohort of patients with Amyotrophic Lateral Sclerosis: the importance of early testing and its implication.
Libonati L; Cambieri C; Colavito D; Moret F; D'Andrea E; Del Giudice E; Leon A; Inghilleri M; Ceccanti M
J Neurol; 2024 Apr; 271(4):1921-1936. PubMed ID: 38112783
[TBL] [Abstract][Full Text] [Related]
12. ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry.
Borghero G; Pugliatti M; Marrosu F; Marrosu MG; Murru MR; Floris G; Cannas A; Parish LD; Cau TB; Loi D; Ticca A; Traccis S; Manera U; Canosa A; Moglia C; Calvo A; Barberis M; Brunetti M; Renton AE; Nalls MA; Traynor BJ; Restagno G; Chiò A;
Neurobiol Aging; 2015 Oct; 36(10):2906.e1-5. PubMed ID: 26208502
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Metabolic Signature of
Calvo A; Canosa A; Moglia C; Manera U; Grassano M; Vasta R; Palumbo F; Cugnasco P; Gallone S; Brunetti M; De Marchi F; Arena V; Pagani M; Dalgard C; Scholz SW; Chia R; Corrado L; Dalfonso S; Mazzini L; Traynor BJ; Chio A
Neurol Genet; 2022 Dec; 8(6):e200033. PubMed ID: 36313067
[TBL] [Abstract][Full Text] [Related]
14. UNC13A influences survival in Italian amyotrophic lateral sclerosis patients: a population-based study.
Chiò A; Mora G; Restagno G; Brunetti M; Ossola I; Barberis M; Ferrucci L; Canosa A; Manera U; Moglia C; Fuda G; Traynor BJ; Calvo A
Neurobiol Aging; 2013 Jan; 34(1):357.e1-5. PubMed ID: 22921269
[TBL] [Abstract][Full Text] [Related]
15. The Clinical and Polynucleotide Repeat Expansion Analysis of
Hou X; Li W; Liu P; Liu Z; Yuan Y; Ni J; Shen L; Tang B; Wang J
Front Neurol; 2022; 13():811202. PubMed ID: 35599735
[TBL] [Abstract][Full Text] [Related]
16. PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats.
Yu Z; Zhu Y; Chen-Plotkin AS; Clay-Falcone D; McCluskey L; Elman L; Kalb RG; Trojanowski JQ; Lee VM; Van Deerlin VM; Gitler AD; Bonini NM
PLoS One; 2011 Mar; 6(3):e17951. PubMed ID: 21479228
[TBL] [Abstract][Full Text] [Related]
17. UNC13A variant rs12608932 is associated with increased risk of amyotrophic lateral sclerosis and reduced patient survival: a meta-analysis.
Yang B; Jiang H; Wang F; Li S; Wu C; Bao J; Zhu Y; Xu Z; Liu B; Ren H; Yang X
Neurol Sci; 2019 Nov; 40(11):2293-2302. PubMed ID: 31201598
[TBL] [Abstract][Full Text] [Related]
18. The most prevalent genetic cause of ALS-FTD, C9orf72 synergizes the toxicity of ATXN2 intermediate polyglutamine repeats through the autophagy pathway.
Ciura S; Sellier C; Campanari ML; Charlet-Berguerand N; Kabashi E
Autophagy; 2016 Aug; 12(8):1406-8. PubMed ID: 27245636
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72.
Chiò A; Borghero G; Restagno G; Mora G; Drepper C; Traynor BJ; Sendtner M; Brunetti M; Ossola I; Calvo A; Pugliatti M; Sotgiu MA; Murru MR; Marrosu MG; Marrosu F; Marinou K; Mandrioli J; Sola P; Caponnetto C; Mancardi G; Mandich P; La Bella V; Spataro R; Conte A; Monsurrò MR; Tedeschi G; Pisano F; Bartolomei I; Salvi F; Lauria Pinter G; Simone I; Logroscino G; Gambardella A; Quattrone A; Lunetta C; Volanti P; Zollino M; Penco S; Battistini S; ; Renton AE; Majounie E; Abramzon Y; Conforti FL; Giannini F; Corbo M; Sabatelli M
Brain; 2012 Mar; 135(Pt 3):784-93. PubMed ID: 22366794
[TBL] [Abstract][Full Text] [Related]
20. Genetic factors for survival in amyotrophic lateral sclerosis: an integrated approach combining a systematic review, pairwise and network meta-analysis.
Su WM; Gu XJ; Duan QQ; Jiang Z; Gao X; Shang HF; Chen YP
BMC Med; 2022 Jun; 20(1):209. PubMed ID: 35754054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
